Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Carlyn Rose Co Tan, Colin Rueda, Tala Shekarkhand, Andriy Derkach, Neha Korde, Kylee Maclachlan, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi A Shah, Sridevi Rajeeve, Oscar Boutros Lahoud, Gunjan L. Shah, Michael Scordo, David J. Chung, Heather Jolie Landau, Sergio Giralt, Saad Zafar Usmani, Alexander M. Lesokhin
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Scientific Affairs
OpenAlex ID: W4399480937